| RS111840903 |
BLTP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alkuraya-Kucinskas syndrome, BLTP1-related disorder |
| RS111846397 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS111846884 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS111848145 |
PIK3R2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome |
| RS111851524 |
CFHR1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS111851677 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
beta Thalassemia, Beta-thalassemia HBB/LCRB |
| RS111851815 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS111852098 |
PTPN23
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS111854391 |
TGFBR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Loeys-Dietz syndrome 1, Loeys-Dietz syndrome |
| RS111854563 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS111856468 |
RNF43
|
Health Risk |
Conflicting classifications of pathogenicity |
Sessile serrated polyposis cancer syndrome, Sessile serrated polyposis cancer syndrome |
| RS111856492 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS111858392 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 4 |
| RS111858832 |
PC
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate carboxylase deficiency, Ovarian serous cystadenocarcinoma |
| RS111859466 |
RAB3GAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Martsolf syndrome, Warburg micro syndrome 2 |
| RS111861429 |
NCKAP5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS111863059 |
NEB
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 6, Arthrogryposis multiplex congenita 6 |
| RS111863748 |
PANK2
|
Health Risk |
Likely pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS111863978 |
GNPTAB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS111865190 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS111866410 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Colorectal adenoma |
| RS111866498 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Schwartz-Jampel syndrome, Lethal Kniest-like syndrome |
| RS111867535 |
KCNJ5
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS111871863 |
ANO10
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive spinocerebellar ataxia 10, Autosomal recessive spinocerebellar ataxia 10 |
| RS111877243 |
DNMT3B
|
Health Risk |
Conflicting classifications of pathogenicity |
Centromeric instability of chromosomes 1, 9 and 16 and immunodeficiency |
| RS111879470 |
MDH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, MDH2-related disorder |
| RS111883853 |
FSHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Ovarian dysgenesis 1, Ovarian hyperstimulation syndrome |
| RS111888148 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS111889921 |
WDR62
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS111901323 |
IFT52
|
Health Risk |
Conflicting classifications of pathogenicity |
IFT52-related disorder, IFT52-related disorder |
| RS111901413 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS111906016 |
ADAMTSL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Geleophysic dysplasia 1, Geleophysic dysplasia 1 |
| RS111906560 |
DNAH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS111909155 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS111911126 |
GYS1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease due to muscle and heart glycogen synthase deficiency, Glycogen storage disease due to muscle and heart glycogen synthase deficiency |
| RS111912673 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS111915712 |
CEP164
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 15, CEP164-related disorder |
| RS111916311 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS111917814 |
CEP152
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 9, primary |
| RS111920492 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS111927109 |
REEP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 72, Hereditary spastic paraplegia 72 |
| RS111927395 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS111929073 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS111929350 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS111933069 |
EIF2B5
|
Health Risk |
Conflicting classifications of pathogenicity |
Vanishing white matter disease, Leukoencephalopathy with vanishing white matter 5 |
| RS111933113 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS111936548 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS111936933 |
ELP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial dysautonomia, Hereditary sensory and autonomic neuropathy |
| RS111939130 |
ADGRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bilateral frontoparietal polymicrogyria, Bilateral frontoparietal polymicrogyria |
| RS111940956 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 4 |
| RS111941389 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 4, Cardiovascular phenotype |
| RS111947397 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa 25 |
| RS111947578 |
DEAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 24 |
| RS111950016 |
LTBP3
|
Health Risk |
Likely pathogenic |
Brachyolmia-amelogenesis imperfecta syndrome, Brachyolmia-amelogenesis imperfecta syndrome |
| RS111950018 |
DAAM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrotic syndrome, type 24 |
| RS111951711 |
SEC23B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cowden syndrome 7, Congenital dyserythropoietic anemia |
| RS111951959 |
HADH
|
Health Risk |
Pathogenic |
Deficiency of 3-hydroxyacyl-CoA dehydrogenase, Deficiency of 3-hydroxyacyl-CoA dehydrogenase |
| RS111953130 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, Nonpapillary renal cell carcinoma |
| RS111957225 |
GH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Decreased response to growth hormone stimulation test, GH1-related disorder |
| RS11196205 |
TCF7L2
|
Health Risk |
risk factor |
Diabetes mellitus type 2, susceptibility to |
| RS111967655 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Diabetes mellitus, transient neonatal |
| RS111969225 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Inborn genetic diseases |
| RS111970242 |
PHKB
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS111972736 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS111972756 |
TNNC1
|
Health Risk |
Pathogenic |
— |
| RS111975186 |
ALDH6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonate semialdehyde dehydrogenase deficiency, ALDH6A1-related disorder |
| RS111976711 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS111978474 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS111978809 |
ARHGEF10
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS111978932 |
FBN1
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS111981744 |
FBN1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS111983425 |
PKD1L1
|
Health Risk |
Conflicting classifications of pathogenicity |
PKD1L1-related disorder, PKD1L1-related disorder |
| RS111984349 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS111986316 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS11199064 |
BAG3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS111991507 |
TMEM67
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS111991705 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 25, Retinitis pigmentosa |
| RS111992415 |
UMOD
|
Health Risk |
Conflicting classifications of pathogenicity |
Kidney disorder, UMOD-related disorder |
| RS111993466 |
INSR
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS111996685 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS112002192 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS112002462 |
TAF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly-thin corpus callosum-intellectual disability syndrome, Microcephaly-thin corpus callosum-intellectual disability syndrome |
| RS112005636 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Stargardt disease, Retinal dystrophy |
| RS11200638 |
HTRA1
|
Health Risk |
risk factor |
Age related macular degeneration 7, Age related macular degeneration 7 |
| RS112007817 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS112009206 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS112016439 |
MYPN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1KK, Cardiovascular phenotype |
| RS112023055 |
ANTXR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyaline fibromatosis syndrome, ANTXR2-related disorder |
| RS112025212 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS112025387 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Marfan syndrome |
| RS112026097 |
NDUFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS112029032 |
HGSNAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-C |
| RS112029328 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercholesterolemia, familial |
| RS112029370 |
CBS
|
Health Risk |
Conflicting classifications of pathogenicity |
Classic homocystinuria, HYPERHOMOCYSTEINEMIA |
| RS112030234 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Inborn genetic diseases |
| RS112030253 |
SERPINA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS11203366 |
PADI4
|
Health Risk |
Benign; association |
Rheumatoid arthritis, Abnormal pulmonary interstitial morphology |
| RS11203367 |
PADI4
|
Health Risk |
Benign; association |
Rheumatoid arthritis, Abnormal pulmonary interstitial morphology |
| RS112034381 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS112034997 |
COL4A6
|
Health Risk |
Conflicting classifications of pathogenicity |
COL4A6-related disorder, COL4A6-related disorder |